Samuel Hou

Person

La Chaux-de-Fonds, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies that bind to OX40 and their uses
- Patent number 12,281,169
- Issue date Apr 22, 2025
- Ichnos Sciences SA
- Antoine Attinger
- G01 - MEASURING TESTING
Information Patent Grant
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...
- Patent number 12,006,367
- Issue date Jun 11, 2024
- Ichnos Sciences SA
- Romain Ollier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Production of T cell retargeting hetero-dimeric immunoglobulins
- Patent number 11,891,454
- Issue date Feb 6, 2024
- Ichnos Sciences SA
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Production of T cell retargeting hetero-dimeric immunoglobulins
- Patent number 11,851,502
- Issue date Dec 26, 2023
- Ichnos Sciences SA
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...
- Patent number 11,773,166
- Issue date Oct 3, 2023
- Ichnos Sciences SA
- Romain Ollier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind to OX40 and their uses
- Patent number 11,407,839
- Issue date Aug 9, 2022
- Ichnos Sciences SA
- Antoine Attinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc variant antibodies and their uses
- Patent number 11,267,891
- Issue date Mar 8, 2022
- Sanofi
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that bind to CCR6 and their uses
- Patent number 10,640,564
- Issue date May 5, 2020
- Ichnos Sciences SA
- Rami Lissilaa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Production of T cell retargeting hetero-dimeric immunoglobulins
- Patent number 9,493,563
- Issue date Nov 15, 2016
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-alpha2 integrin antibodies and their uses
- Patent number 8,975,376
- Issue date Mar 10, 2015
- Sanofi
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that bind to OX40 and their uses
- Patent number 8,748,585
- Issue date Jun 10, 2014
- Glenmark Pharmaceuticals S.A.
- Antoine Attinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies specific for von Willebrand factor
- Patent number 8,236,315
- Issue date Aug 7, 2012
- Glenmark Pharmaceuticals, S.A.
- Elias Lazarides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...
- Publication number 20230062624
- Publication date Mar 2, 2023
- Ichnos Sciences SA.
- Romain OLLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT BIND TO OX40 AND THEIR USES
- Publication number 20220411526
- Publication date Dec 29, 2022
- Ichnos Sciences SA.
- Antoine ATTINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS
- Publication number 20210171661
- Publication date Jun 10, 2021
- Ichnos Sciences SA.
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies That Bind To OX40 and Their Uses
- Publication number 20200071409
- Publication date Mar 5, 2020
- Glenmark Pharmaceuticals S.A.
- Antoine ATTINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...
- Publication number 20190135918
- Publication date May 9, 2019
- Glenmark Pharmaceuticals S.A.
- Romain OLLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS
- Publication number 20180355064
- Publication date Dec 13, 2018
- Glenmark Pharmaceuticals S.A.
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND TO CCR6 AND THEIR USES
- Publication number 20180086836
- Publication date Mar 29, 2018
- Glenmark Pharmaceuticals S.A.
- Rami LISSILAA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies that Bind to OX40 and Their Uses
- Publication number 20170260280
- Publication date Sep 14, 2017
- Glenmark Pharmaceuticals S.A.
- Antoine Attinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Production of T cell retargeting hetero-dimeric immunoglobulins
- Publication number 20170145115
- Publication date May 25, 2017
- Glenmark Pharmaceuticals S.A.
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES
- Publication number 20150232559
- Publication date Aug 20, 2015
- SANOFI
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Production of T cell retargeting hetero-dimeric immunoglobulins
- Publication number 20150133640
- Publication date May 14, 2015
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND TO OX40 AND THEIR USES
- Publication number 20140294824
- Publication date Oct 2, 2014
- Glenmark Pharmaceuticals S.A.
- Antoine Attinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies that bind to OX40 and their uses
- Publication number 20130183315
- Publication date Jul 18, 2013
- Glenmark Pharmaceuticals S.A.
- Antoine Attinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES
- Publication number 20130052191
- Publication date Feb 28, 2013
- SANOFI
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTIBODIES SPECIFIC FOR VON WILLEBRAND FACTOR
- Publication number 20090232804
- Publication date Sep 17, 2009
- GLENMARK PHARMACEUTICALS, S.A.,
- Elias Lazarides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Antibodies that bind to OX40 and their uses

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...

Production of T cell retargeting hetero-dimeric immunoglobulins

Production of T cell retargeting hetero-dimeric immunoglobulins

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...

Antibodies that bind to OX40 and their uses

Fc variant antibodies and their uses

Antibodies that bind to CCR6 and their uses

Production of T cell retargeting hetero-dimeric immunoglobulins

Anti-alpha2 integrin antibodies and their uses

Antibodies that bind to OX40 and their uses

Humanized antibodies specific for von Willebrand factor

Patents Applicationslast 30 patents

CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...

ANTIBODIES THAT BIND TO OX40 AND THEIR USES

PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

Antibodies That Bind To OX40 and Their Uses

CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...

PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

ANTIBODIES THAT BIND TO CCR6 AND THEIR USES

Antibodies that Bind to OX40 and Their Uses

Production of T cell retargeting hetero-dimeric immunoglobulins

ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES

Production of T cell retargeting hetero-dimeric immunoglobulins

ANTIBODIES THAT BIND TO OX40 AND THEIR USES

Antibodies that bind to OX40 and their uses

ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES

HUMANIZED ANTIBODIES SPECIFIC FOR VON WILLEBRAND FACTOR